Who are Autolus Therapeutics plc's main suppliers?

Autolus Therapeutics plc (AUTL) key suppliers include: AGC-BIOLOGICS-S-P-A, CONTRACT-RESEARCH-ORGANIZATION, BioNTech SE, BioNTech SE, Artiva Biotherapeutics, Inc. and 2 more. View the full supplier network at chainsifter.com/chain/AUTL.

Who are Autolus Therapeutics plc's major customers?

Autolus Therapeutics plc (AUTL) key customers include: NATIONAL-HEALTH-SERVICE, BioNTech SE, BioNTech SE, Legend Biotech Corporation, TScan Therapeutics, Inc.. View the full customer network at chainsifter.com/chain/AUTL.

What sector is Autolus Therapeutics plc in?

Autolus Therapeutics plc (AUTL) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Autolus Therapeutics plc Suppliers, Customers & Supply Chain (AUTL)

7Suppliers

5Customers

1Debt Items

20Related Chains

Source-Backed Evidence Depth

Autolus Therapeutics plc (AUTL) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

14Total relationships

3Distinct source URLs

7High confidence

0.794Average confidence

2026-10-28Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Autolus Therapeutics plc Suppliers

Ticker	Name	Confidence	Evidence
AGC-BIOLOGICS-S-P-A	AGC-BIOLOGICS-S-P-A	92%	The Agreement replaces and supersedes the prior arrangement between the Company and AGC, pursuant to which AGC has provided similar products and services.
CONTRACT-RESEARCH-ORGANIZATION	CONTRACT-RESEARCH-ORGANIZATION	85%	Qualifying expenditures largely comprise of employment costs for research staff, consumables, outsourced contract research organization costs and utilities costs incurred as part of research projects…
BNTX	BioNTech SE	80%	Reciprocal relationship from BNTX graph: Reciprocal relationship from AUTL graph: Reciprocal relationship from BNTX graph: Reciprocal relationship from AUTL graph: As the Product Options within the B…
BNTX	BioNTech SE	80%	As the Product Options within the BioNTech License and Option Agreement were an embedded feature within a freestanding financial instrument, the Company assessed if the Product Options should be acco…
ARTV	Artiva Biotherapeutics, Inc.	72%	Reciprocal relationship from ARTV graph: uture environmental regulations may impair our research, development and production efforts, which could harm our business, prospects, financial condition or …
CLLS	Cellectis S.A.	72%	Reciprocal relationship from CLLS graph: Reciprocal relationship from AUTL graph: Reciprocal relationship from CLLS graph: ately 14,000 sq. ft. in-house manufacturing facility, which is dedicated to …
LEGN	Legend Biotech Corporation	72%	Reciprocal relationship from LEGN graph: supply chain disruptions, failure of financial institutions, rising inflation, tariffs and other world events; • comply with applicable legal and regulatory r…

Autolus Therapeutics plc Customers

Ticker	Name	Confidence	Evidence
NATIONAL-HEALTH-SERVICE	NATIONAL-HEALTH-SERVICE	90%	AUCATZYL is available through the National Health Service ("NHS") and private treatment centers.
BNTX	BioNTech SE	72%	Reciprocal relationship from BNTX graph: Reciprocal relationship from AUTL graph: Reciprocal relationship from BNTX graph: Reciprocal relationship from AUTL graph: expenses, including salaries, relat…
BNTX	BioNTech SE	72%	expenses, including salaries, related benefits, travel and share-based compensation expense for employees engaged in commercial manufacturing functions, external manufacturing costs including outsour…
LEGN	Legend Biotech Corporation	72%	Reciprocal relationship from LEGN graph: ct and product candidates have a limited window of stability following apheresis from a patient, we must establish and employ complex logistical operations, i…
TCRX	TScan Therapeutics, Inc.	72%	Reciprocal relationship from TCRX graph: Reciprocal relationship from AUTL graph: Reciprocal relationship from TCRX graph: Reciprocal relationship from AUTL graph: Reciprocal relationship from TCRX g…

Autolus Therapeutics plc Debt Obligations

Instrument	Description	Confidence	Evidence
AUTL-DEBT-7986	Warrants outstanding: 7.35	90%	xbrl warrant detail from xbrl 2021-12-31.

Autolus Therapeutics plc Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Autolus Therapeutics plc.

Autolus Therapeutics plc Ownership

Holder	Name	Confidence	Evidence
AUTL-OWNER-MAK-CAPITAL-ONE-LLC	MAK CAPITAL ONE LLC	90%	13F overlay lists MAK CAPITAL ONE LLC as top holder; 84 tracked holders.

Autolus Therapeutics plc Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
RNAC	Cartesian Therapeutics, Inc.	100.00	2
ROIV	Roivant Sciences Ltd.	100.00	2
MGNX	MacroGenics, Inc.	100.00	2
TCRX	TScan Therapeutics, Inc.	100.00	1	['customer']
ALLO	Allogene Therapeutics, Inc.	100.00	2
CRBU	Caribou Biosciences, Inc.	100.00	2
IPSC	Century Therapeutics, Inc.	100.00	2
MYGN	Myriad Genetics, Inc.	100.00	2
BCAX	Bicara Therapeutics Inc.	100.00	2
CBIO	Crescent Biopharma, Inc.	100.00	2
ARTV	Artiva Biotherapeutics, Inc.	100.00	1	['supplier']
BNTX	BioNTech SE	100.00	1	['customer', 'supplier']
REGN	Regeneron Pharmaceuticals, Inc.	100.00	2
CLLS	Cellectis S.A.	100.00	1	['supplier']
DTIL	Precision BioSciences, Inc.	100.00	2
BMY	Bristol-Myers Squibb Company	100.00	2
BMYMP	Bristol-Myers Squibb Co	100.00	2
TKPHF	Takeda Pharmaceutical Company Limited	100.00	2
GSK	GSK plc	100.00	2
TMO	Thermo Fisher Scientific Inc.	100.00	2

Autolus Therapeutics plc Supply Chain